Sana Biotechnology, Inc.
SANA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $208,683 | $219,842 | $201,003 | $306,499 |
| G&A Expenses | $64,040 | $73,299 | $71,561 | $50,410 |
| SG&A Expenses | $64,040 | $73,299 | $71,561 | $50,410 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $272,723 | $293,141 | $272,564 | $356,909 |
| Operating Income | -$272,723 | -$293,141 | -$272,564 | -$356,909 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $5,964 | $9,886 | $3,088 | $981 |
| Pre-Tax Income | -$266,759 | -$283,255 | -$269,476 | -$355,928 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$266,759 | -$283,255 | -$269,476 | -$355,928 |
| % Margin | – | – | – | – |
| EPS | -1.16 | -1.46 | -1.43 | -2.14 |
| % Growth | 20.5% | -2.1% | 33.2% | – |
| EPS Diluted | -1.16 | -1.46 | -1.43 | -2.14 |
| Weighted Avg Shares Out | 230,891 | 194,541 | 188,344 | 166,433 |
| Weighted Avg Shares Out Dil | 230,891 | 194,541 | 188,344 | 166,433 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,471 | $9,938 | $3,762 | $676 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $17,391 | $24,557 | $15,625 | $11,070 |
| EBITDA | -$255,332 | -$268,584 | -$256,939 | -$345,839 |
| % Margin | – | – | – | – |